New EULAR recommendations for vasculitis

The European League Against Rheumatism has updated its 2009 recommendations for ANCA-associated vasculitis (AAV), taking account of new developments including the use of rituximab in treating the disease.

EULAR says it is labeling its advice as “recommendations” rather than “guidelines” as treatment needs to be tailored to meet the individual requirements of patients.

It says the update was